The ECP/Eo Count Ratio in Children with Asthma

References

• Bousquet J, Courigan C J, Venge P. Peripheral blood markers: evaluation and inflammation in asthma. Eur Respir J 1998; 26: 42–48
   Google Scholar
• Grutters J C, Brinkman L, Aslander M M, van den Bosch J M, Koenderman L, Lammers J W. Asthma therapy modulates priming‐associated blood eosinophil responsiveness in allergic asthmatics. Eur Respir J 1999; 14: 915–922, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Crimi E, Spanevello A, Neri M, Ind P W, Rossi G A, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998; 157: 4–9, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Daher S, Santos L M, Sole D, De Lima M G, Naspitz C K, Musatti C C. Interleukin 4 and soluble CD23 serum levels in asthmatic atopic children. J Investig Allergol Clin Immunol 1995; 5: 251–254, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Koller D Y, Herouy Y, Gotz M, Hagel E, Urbanek R, Eichler I. Clinical value of monitoring eosinophil activity in asthma. Arch Dis Child 1995; 73: 413–417, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Pizzichini E, Pizzichini M M, Efthimiadis A, Dolovich J, Hargreave F E. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol. 1997; 99: 539–544, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Wardlaw A J, Brightling C E, Green R, Woltmann G, Bradding P, Pavord I D. New insights into the relationship between airway inflammation and asthma. Clin Sci (Lond) 2002; 103: 201–211, [CSA]
   PubMed Web of Science ®Google Scholar
• Motojima S, Ogata H, Tateishi K, Fukuda T, Makino S, Koseki T, Adachi T, Kihara N. Measurement of serum and sputum eosinophil cationic protein concentration in asthma. Arerugi 1995; 44: 1272–1281, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Zimmerman B, Lanner A, Enanober I. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Clin Exp Allergy 1993; 23: 564–570, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gruber W, Eber E, Pfleger A, Modl M, Meister I, Weinhandl E, Zach M S. Serum eosinophil cationic protein and bronchial responsiveness in pediatrics and adolescent asthma patients. Chest 1999; 116: 301–305, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Fuijtaka M, Kawaguchi H, Kato Y, Sakura N, Ueda K, Abe Y. Significance of the eosinophil cationic protein/eosinophil count ratio in asthmatic patients: its relationship to disease severity. Ann Allergy Asthma Immunol 2001; 86: 323–329
   Google Scholar
• Imai C, Yamazaki H, Tanaka Y, Matsunaga M, Numata O, Torigoe K. Ratio of eosinophil cationic protein count as a new marker in children with acute asthma. Pediatr Int 1999; 41: 142–146, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Koh Y Y, Kang H, Kim C K. Ratio of serum eosinophil cationic protein/blood eosinophil counts in children with asthma: comparison between acute exacerbation and clinical remission. Allergy Asthma Proc. 2003; 24: 269–274, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Lai C K, Chan C H, Leung J C, Lai K N. Serum concentration of soluble interleukin 2 receptors in asthma. Correlation with disease activity. Chest 1993; 103: 782–786, [INFOTRIEVE]
   Google Scholar
• Tsai L C, Tang R B, Hung M W, Chen H M, Tsai S J. Expression of serum Il–2, Il‐2R, and CD8 levels during hyposensitization in house dust‐sensitive asthmatics. J Asthma 1990; 27: 307–313, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• El Sawy I H, Badr‐El‐Din O M, El‐Azzouni O E, Motawae H A. Soluble intercelluar adhesion molecule—1 in sera of children with bronchial asthma exacerbation. Arch Allergy Immunol 1999; 119: 126–132, [CROSSREF]
   Google Scholar
• Shiota Y, Wilson J G, Marukana M, Ono T, Kaji M. Soluble intercellular adhesion molecule 1 (ICAM–1) antigen in sera of bronchial asthmatics. Chest 1996; 109: 94–99, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Highlights of the Expert Panel Report 2. Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 97‐4051A. May 1997
   Google Scholar
• Santanello N C, Barber B L, Reiss T F, Friedman B S, Juniper E F, Zhang J. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J 1997; 10: 646–651, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cockcroft D W, Murdock K Y, Mink JT. Determination of Histamine PC20. Chest 1983; 54: 505–506
   Google Scholar
• Wever A M, Wever‐Hess J, Hensgens H E, Hermans J. Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow‐volume curves, PC20, and exacerbations. Respir Med. 1994; 88: 613–621, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Vatrella A, Ponticello A, Parella R, Romano L, Zofra S, DiLeva A, Bariffi F. Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma. Allergy 1996; 51: 547–555, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Fergusson A C, Vaughan R, Brown H, Curtis C. Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma. J Allergy Clin Immunol 1995; 95: 23–28, [CSA]
   Google Scholar
• Ronchi M C, Piragino C, Rosi E, Stendardi L, Tanini A, Galli G, Duranti R, Scano G. Do sputum eosinophil and ECP relate to severity of asthma?. Eur Respir J 1997; 10: 1809–1813, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Prehn A, Seger R A, Faber J, Torresani T, Molinari L, Gerber A, Sennhauser F H. The relationship of serum‐eosinophil cationic protein and eosinophil count to disease activity in children with bronchial asthma. Pediatr Allergy Immunol 1998; 9: 197–203, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Vanto T, Koskinen P. Serum eosinophil cationic protein in the evaluation of asthma severity in children. Allergy 1998; 53: 415–419, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ferdousi H A, Dreborg S. Asthma, bronchial hypereactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity. Clin Exp Allergy 1996; 27: 530–539, [CROSSREF], [CSA]
   Google Scholar
• Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma. Clin Exp Allergy 1998; 28: 233–240, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Pronk‐Admiraal C J, Haitjema T, Horikx P, Bartels P C. Surplus value of eosinophil count and ECP to diagnose and monitor asthmatic patients. Neth J Med. 2001; 58: 9–17, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Obase Y, Shimoda T, Mitsuta K, Matsuo N, Matsuse H, Kohno S. Sensitivity to the house dust mite and airway hyperresponsiveness in a young adult population. Ann Allergy Asthma Immunol 1999; 83: 305–310, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Shi H Z, Sun J J, Pan H L, Lu J Q, Zhang J L, Jiang J D. Alternations of T‐lymphocyte subsets, soluble IL‐2 receptor and IgE in peripheral blood of children with acute asthma attacks. J Allergy Clin Immunol 1999; 103: 388–392, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Cengizlier R, Demirpolat E, Tulek N, et al. Circulating ICAM‐1 levels in bronchial asthma and the effect of inhaled corticosteroids. Ann Allergy Asthma Immunol 2000; 84: 539–541, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Pronk‐Admiraal C J, Bartels P CM, Mulder K. Eosinophil cationic protein in serum from nonatopic and asymptomatic atopic individuals after standardized blood clotting at 37 C. Ann Clin Biochem 1999; 36: 353–358
   Google Scholar
• Sont J K, Willems L N, Bel E H, van Krieken J H, Vandenbroucke J P, Sterk P J. Clinical control and histopatologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long‐term treatment. Am J Respir Crit Care Med. 1999; 159: 1043–1051, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar